SIBO (Small Intestinal Bacterial Overgrowth): Symptoms, Testing, and Protocols

What is SIBO and Why Does Small Intestinal Bacterial Overgrowth Occur?

Small Intestinal Bacterial Overgrowth (SIBO) is defined as an abnormal accumulation of bacteria within the small intestine, exceeding 1,000 colony-forming units per milliliter (CFU/mL). The human digestive tract is anatomically partitioned: while the large intestine houses hundreds of trillions of fermentative microbes, the healthy upper small intestine is naturally maintained in a relatively sparse microbial state to facilitate unimpeded nutrient absorption. PMID 32467262

In SIBO, opportunistic bacteria retrograde from the cecum or colon, colonizing the duodenum, jejunum, and ileum. When dietary carbohydrates or soluble fibers are consumed, these bacteria ferment nutrients prematurely, hours before systemic host absorption can occur. This leads to intense luminal gas generation, mucosal irritation, and widespread malabsorption of proteins, fat-soluble vitamins, and vitamin B12. PMID 32467262

Relapse prevention represents the single most crucial challenge in clinical SIBO management. Without addressing impaired intestinal motility and the Migrating Motor Complex (MMC), clinical relapse occurs in up to 40–60% of patients within 3 to 6 months post-clearing. PMID 32467262

When the small intestine is inundated with bacteria, microbes deconjugate primary bile acids prematurely. This impairs micelle formation, precipitating lipid malabsorption, deficiencies in fat-soluble vitamins (A, D, E, and K), and chronic chemical irritation of enterocytes. PMID 32467262

Three Types of SIBO: Hydrogen, Methane (IMO), and Hydrogen Sulfide

Depending on the dominant microbial species colonizing the small intestine, SIBO is clinically classified into three distinct subtypes: PMID 28323614 PMID 32023228

1. **Hydrogen-Dominant SIBO (H2)**: Driven by overgrowth of Gram-negative facultative anaerobes such as *Escherichia coli* and *Klebsiella pneumoniae*. These organisms rapidly ferment carbohydrates into hydrogen gas, causing accelerated intestinal transit, cramping, and osmotic diarrhea. PMID 28323614 PMID 32023228

2. **Intestinal Methanogen Overgrowth (IMO)**: Driven not by true bacteria, but by methanogenic archaea, predominantly *Methanobrevibacter smithii*. These archaea consume hydrogen to produce methane gas (CH4), which acts as a neurochemical paralytic on enteric smooth muscle, inducing profound constipation and distension. PMID 28323614 PMID 32023228

3. **Hydrogen Sulfide SIBO (H2S)**: Mediated by sulfate-reducing bacteria such as *Desulfovibrio*. They generate toxic hydrogen sulfide gas with a characteristic rotten-egg odor, often presenting with severe visceral hypersensitivity, abdominal pain, and body-wide aches. PMID 28323614 PMID 32023228

According to the North American Consensus, diagnostic breath testing thresholds are well-established: a rise in hydrogen of at least 20 ppm over baseline within 90 minutes confirms hydrogen SIBO, while methane concentrations of 10 ppm or greater at any point during testing confirm IMO. PMID 28323614 PMID 32023228

The Migrating Motor Complex (MMC) — The Gut's Automatic Sweeper

The leading underlying pathophysiological driver of SIBO onset and recurrence is failure of the Migrating Motor Complex (MMC). The MMC is an electro-mechanical sweeping wave initiated in the stomach and propagating through the small intestine during fasting states — repeating every 90 to 120 minutes between meals and overnight. PMID 24891990 PMID 26071477

This wave propels cellular debris, food remnants, and transient bacteria downstream into the cecum. Continuous snacking triggers insulin and gastrin secretion, abruptly aborting the MMC cycle. Furthermore, post-infectious food poisoning can trigger molecular mimicry: bacterial cytolethal distending toxin B (CdtB) induces autoantibodies against vinculin, damaging interstitial cells of Cajal and paralyzing MMC activity. PMID 24891990 PMID 26071477

Supporting the MMC requires deliberate meal spacing: implementing 4–5 hour intervals between meals enables Phase III MMC sweeping to complete unimpeded. Administering botanical prokinetics (standardized ginger root and artichoke leaf extract) at bedtime further optimizes nocturnal cleansing sweeps. PMID 24891990 PMID 26071477

Diagnosis via Breath Testing and the 3-Step Treatment Protocol

The clinical gold standard for non-invasive SIBO diagnosis is a 2–3 hour **Lactulose Breath Test**. Because human enterocytes lack enzymes to metabolize lactulose, it traverses the small intestine intact; any gas rise within the initial 90 minutes directly pinpoints small bowel bacterial fermentation. PMID 26071477

**The Evidence-Based 3-Step Treatment Protocol**: PMID 26071477

1. **Targeted Antimicrobial Eradication**: Eradicating bacterial overgrowth using the minimally absorbed oral antibiotic **Rifaximin** or broad-spectrum botanical microbials (berberine hydrochloride, neem extract, oil of oregano, and allicin). PMID 26071477

2. **Motility Restoration (Prokinetics)**: Initiating prokinetic therapy (ginger/artichoke formulations or low-dose naltrexone) immediately upon completing antimicrobial therapy to sustain MMC activity and prevent rapid recolonization. PMID 26071477

3. **Mucosal Barrier & Microbiome Repair**: Healing the intestinal epithelium with L-glutamine, zinc carnosine, and a stepwise reintroduction of low-fermentation prebiotic fibers. PMID 26071477

Pharmacologically, Rifaximin (550 mg three times daily for 14 days) remains the first-line therapy for hydrogen SIBO, featuring less than 0.4% systemic absorption. For methane overgrowth (IMO), Rifaximin is combined with Neomycin (500 mg twice daily) or Metronidazole to eradicate archaeal populations effectively. PMID 26071477